Advertisment
 

Join the Topix community today: 

Sign Up

 | 

Sign In

PharmaThene gets more funding for anthrax drug

By Andrea K. Walker

Baltimore Sun

January 08, 2008

PharmaThene Inc., an Annapolis company that develops countermeasures against biological and chemical threats, said this morning that the Department of Defense fiscal 2008 budget includes up to $1.6 million for development of its anthrax antitoxin Valortim. The drug is being developed with New Jersey-based Medarex Inc.

The federal government has pledged an additional $23 million in the last four fiscal years to develop Valortim, the company said.

PharmaThene shares closed at $3.87 on the American Stock Exchange yesterday.

andrea.walker@baltsun.com

Copyright © 2008 Baltimore Sun, All Rights Reserved.

COMMENT ON THE STORY

Type in your comments to post to the forum
Name
(appears on your post)
Comments
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.